Eisai Gets Japan Indication For Warfarin Anticoagulant For Children
This article was originally published in PharmAsia News
Executive Summary
Eisai said its Warfarin (warfarin) anti-coagulant has received Japanese approval as an expanded treatment for pediatric patients, making Japan only the second nation to do so